CIPO Patents = 1

EPO Patents = 2

Forward Citations = 45

Loading Chart...

4 inventors (with patents filed for the assignee):

Charles D Smith (5 out of 25 patents)

Yan Zhuang (5 out of 5 patents)

Kevin J French (4 out of 6 patents)

4. Lynn W Maines (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. RE49811 - Sphingosine kinase inhibitors (2024-01-23),

2. 8685936 - Sphingosine kinase inhibitor prodrugs (2014-04-01),

3. 8557800 - Sphingosine kinase inhibitors (2013-10-15),

4. 8063248 - Sphingosine kinase inhibitors (2011-11-22),

5. 7338961 - Sphingosine kinase inhibitors (2008-03-04),

Apogee Biotechnology Corporation is a leading biotechnology company focused on developing novel therapies for cancer and other diseases. With a commitment to scientific excellence and innovation, Apogee is dedicated to improving patient outcomes through the discovery and development of cutting-edge treatments. The company's pipeline includes several promising drug candidates in preclinical and clinical development, targeting a range of oncology indications. Visit our website to learn more about our mission and research programs.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

5 Patents

#3 in Hershey, PA

#1,868 in Pennsylvania

#51,545 in US

Hershey, PA, United States of America

Apogee Biotechnology Corporation

Forward Citations = 45

4 inventors:

Charles D Smith (5 out of 25 patents)

Yan Zhuang (5 out of 5 patents)

Kevin J French (4 out of 6 patents)

4. Lynn W Maines (1 out of 2 patents)

Please report any incorrect information to [email protected]

1 patent (CIPO):

Please report any incorrect information to [email protected]

2 patents (EPO):

Please report any incorrect information to [email protected]